Bausch Health
BHC
#5101
Rank
HK$14.37 B
Marketcap
HK$38.50
Share price
2.08%
Change (1 day)
-28.61%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -HK$25.40

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -HK$25.41. In 2025 the company made an earnings per share (EPS) of HK$3.29 an increase over its 2024 EPS that were of -HK$0.94.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$25.40-871.3%
2025HK$3.29-450%
2024-HK$0.94-92.59%
2023-HK$12.70160.89%
2022-HK$4.87-76.64%
2021-HK$20.8468.45%
2020-HK$12.37-68.91%
2019-HK$39.79-57.11%
2018-HK$92.79-272.22%
2017HK$53.88-199.29%
2016-HK$54.26798.7%
2015-HK$6.04-128.31%
2014HK$21.33-204.62%
2013-HK$20.39602.7%
2012-HK$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.88-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.45-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA